To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia

Summary

Investigate the long-term(52 weeks) safety and efficacy of HSK16149 capsules in Chinese patients with periphcral neuralgia

Timeline

Start

2022-02-17

Primary completion

2023-07-30

Completion

2023-08-07

Publications

• Guo X, Wang K, Zhang T, Ma J, Li Y, Jiang C, Liu J, Zhang Y, Bian F, Zhang F, Liu W, Wu X, Tang X, Wang Y, Ning T, Pang S, Li Y, Wang L, Sun J, Hu H, Mao H, Pan T, Li Y, Sun X, Li P, Li F, Huang Q, Li Y. Long-Term Safety and Efficacy of Crisugabalin for Diabetic Peripheral Neuropathic Pain: A 52-Week, Multicenter, Single-Arm Trial. J Diabetes Res. 2026;2026(1):e2960736. doi: 10.1155/jdr/2960736.

Drugs

Indications